Posted by Michael Wonder on 14 Apr 2026
Cancer patient’s plea for Pfizer to rejoin PBS talks on breakthrough drug
14 April 2026 - Pharmaceutical giant Pfizer has abandoned negotiations to have a breakthrough cancer drug listed on the Pharmaceutical Benefits Scheme, sparking fears this could be a result of US driven pressure about the nation’s medicines policies.
The move has come as a devastating blow to patients with stage-four cancer who had been hoping to get more affordable access to the drug.
